Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.
about
Orthopoxvirus genes that mediate disease virulence and host tropismCharacterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T CellsThe poxvirus A35 protein is an immunoregulatorDual neonate vaccine platform against HIV-1 and M. tuberculosis.Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutininInterplay between modified vaccinia virus Ankara and dendritic cells: phenotypic and functional maturation of bystander dendritic cells.Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.Immune modulation in primary vaccinia virus zoonotic human infectionsFunctional paralysis of GM-CSF-derived bone marrow cells productively infected with ectromelia virus.Vaccination and the TAP-independent antigen processing pathways.Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.Antigen presentation assays to investigate uncharacterized immunoregulatory genes.Vaccinia virus A35R inhibits MHC class II antigen presentation.Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
P2860
Q21285044-A8D49CEB-8FAA-4C87-A7B8-593851BB97B0Q28602577-09AA74BF-2EC0-421D-8D26-DF98CFD2696EQ33558734-ACADDEBA-6AAC-44DE-AE42-E8A4C70661A3Q33908584-B349B44D-5E74-4473-BD29-08FB229E0F0DQ34147894-F82DC3AD-CE0D-459E-9F8D-CC87EE30D855Q34982651-B699B695-BEB0-49D9-B4C9-A914EF4E47B1Q35641132-3022BCFA-24BB-4332-87AF-36969BB5F345Q35645804-DA00FF53-AC0C-4361-A00F-770438CB1306Q36399165-6BAFAA28-C288-410F-BFD8-A162D216D65AQ38140044-64B3212F-1153-4CE2-85B2-B910DEAEF096Q39065691-5D1DB4E5-DC1B-4009-B53C-CCF79D9C4665Q39332990-2329D110-1C8A-40D0-BA56-AA87B9A5EFF2Q39390434-20CCCBAF-011B-46DB-9031-B71F47144A77Q55001866-A3946C8E-EA7C-49B6-B974-88580D6A126F
P2860
Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Vaccinia virus decreases major ...... association with MHC class II.
@en
Vaccinia virus decreases major ...... association with MHC class II.
@nl
type
label
Vaccinia virus decreases major ...... association with MHC class II.
@en
Vaccinia virus decreases major ...... association with MHC class II.
@nl
prefLabel
Vaccinia virus decreases major ...... association with MHC class II.
@en
Vaccinia virus decreases major ...... association with MHC class II.
@nl
P2093
P2860
P1433
P1476
Vaccinia virus decreases major ...... association with MHC class II.
@en
P2093
Gwendolyn J B Jones
Kenneth Yimbu
Kristina E Rehm
Ramsey F Connor
P2860
P304
P356
10.1111/J.1365-2567.2009.03120.X
P577
2009-11-01T00:00:00Z